UMSOM and Groupe De Recherche Action en Sante Begin Second Typhoid Conjugate Vaccine Study in Africa

Posted on by
  • Scientists will vaccinate 250 participants aged nine months to two years old in Burkina Faso with typhoid conjugate vaccine
  • Data from the study are expected to help inform policymakers about implementing a mass TCV campaign in Burkina Faso
  • The vaccine study is a joint effort by the Center for Vaccine Development and Global Health (CVD) at the University of Maryland School of Medicine, (UMSOM) and Groupe de Recherche Action en Santé (GRAS) in Burkina Faso